Fosinopril patient counseling information: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Fosinopril#Patient Counseling Information]]
{{Fosinopril}}
{{CMG}}; {{AE}} {{AM}}
 
===Information for Patients===
 
====Angioedema====
 
Angioedema, including [[laryngeal edema]], can occur with treatment with ACE inhibitors, especially following the first dose. Patients should be advised to immediately report to their physician any signs or symptoms suggesting angioedema (e.g., swelling of face, eyes, lips, tongue, larynx, mucous membranes, and extremities; difficulty in swallowing or breathing; [[hoarseness]]) and to discontinue therapy.
 
====Symptomatic Hypotension====
 
Patients should be cautioned that [[lightheadedness]] can occur, especially during the first days of therapy, and it should be reported to a physician. Patients should be told that if syncope occurs, fosinopril Na tablets should be discontinued until the physician has been consulted.
 
All patients should be cautioned that inadequate fluid intake or excessive [[perspiration]], [[diarrhea]], or [[vomiting]] can lead to an excessive fall in blood pressure, with the same consequences of lightheadedness and possible [[syncope]].
 
====Hyperkalemia====
 
Patients should be told not to use potassium supplements or salt substitutes containing [[potassium]] without consulting the physician.
 
====Neutropenia====
 
Patients should be told to promptly report any indication of infection (e.g., [[sore throat]], [[fever]]), which could be a sign of [[neutropenia]].
 
====Pregnancy====
 
Female patients of childbearing age should be told about the consequences of exposure to fosinopril during pregnancy. Discuss treatment options with women planning to become pregnant. Patients should be asked to report pregnancies to their physicians as soon as possible.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = FOSINOPRIL NA (FOSINOPRIL SODIUM) TABLET [APOTEX CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eaa753e8-9fda-af0b-9d54-bdf0d1674832 | publisher =  | date =  | accessdate = }}</ref>
 
==References==
{{Reflist}}
 
{{FDA}}
 
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 00:52, 22 July 2014